Study on NIRS for Early Diagnosis of NEC in Neonates
A study is evaluating the cerebro-splanchnic oxygenation ratio (CSOR) using NIRS for diagnosing NEC in neonates.
Phase III
Pediatrics / Necrotizing Enterocolitis
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study could significantly impact the early diagnosis of necrotizing enterocolitis (NEC) in neonates, potentially leading to improved treatment outcomes. The findings may also influence market dynamics and clinical practices in neonatal care, making it essential for pharma strategy teams to stay informed.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from this trial and any subsequent changes in clinical guidelines for NEC diagnosis.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.